All Stories

  1. Letter: bleeding in cirrhotics receiving coronary stenting and antiplatelet therapy
  2. Alpha1-antitrypsin deficiency and c-JUN
  3. Application of proteomics to the study of Helicobacter pylori and implications for the clinic
  4. Anti-phospholipid syndrome therapy
  5. Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT
  6. Infectious Burden and Semen Parameters
  7. Proteomic Investigation of Dermal Fibroblasts Isolated from Affected and Unaffected Skin Samples from Patients with Limited Cutaneous Systemic Sclerosis: 2 Distinct Entities?
  8. Antiphospholipid syndrome, preeclampsia, and infection byHelicobacter pylori
  9. A milder phenotype of Graves’ disease in recent years in Italy
  10. Comment on ‘Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung’
  11. High hepatocellular carcinoma risk among US-born Hispanics
  12. Preeclampsia relates to H.pylori
  13. Erythema nodosum associated with Staphylococcus xylosus septicemia
  14. Histological variety of gastric carcinoma and Helicobacter pylori cagA and vacA polymorphism
  15. Reply
  16. Sperm Parameters and Semen Levels of Inflammatory Cytokines in Helicobacter pylori–infected Men
  17. Resistin, interleukin-6, tumor necrosis factor-alpha, and human semen parameters in the presence of leukocytospermia, smoking habit, and varicocele
  18. Influence of Helicobacter pylori infection on metabolic parameters and body composition of dyslipidemic patients
  19. CanHelicobacter pyloriinfection influence human reproduction?
  20. Cross-sectional study: CagA–positiveHelicobacter pyloriinfection, acute coronary artery disease and systemic levels of B-type natriuretic peptide
  21. New non-alcoholic formulation for hand disinfection
  22. Immunolocalisation of ghrelin and obestatin in human testis, seminal vesicles, prostate and spermatozoa
  23. Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis
  24. CagA-PositiveHelicobacter pyloriInfection and Reduced Sperm Motility, Vitality, and Normal Morphology
  25. cagA structural types of Helicobacter pylori strains isolated from patients with gastric carcinoma and chronic gastritis only
  26. Helicobacter pylori Infection and Reproductive Disorders
  27. Polysorbate 80 and Helicobacter pylori: a microbiological and ultrastructural study
  28. Influence of Helicobacter pylori Infection on Levels of Ghrelin and Obestatin in Human Semen
  29. Increased Susceptibility to Resveratrol ofHelicobacter pyloriStrains Isolated from Patients with Gastric Carcinoma
  30. Detection of obestatin in seminal plasma and its relationship with ghrelin and semen parameters
  31. Effect of trans-resveratrol on induced oxidative stress in human sperm and in rat germinal cells
  32. Extragastric Manifestations of Helicobacter pylori Infection
  33. Antimicrobial activity against Helicobacter pylori strains and antioxidant properties of blackberry leaves (Rubus ulmifolius) and isolated compounds
  34. NegativeHelicobacter pyloristatus is associated with poor prognosis in patients with gastric cancer
  35. Infection by CagA-Positive Helicobacter pylori Strains may Contribute to Alter the Sperm Quality of Men with Fertility Disorders and Increase the Systemic Levels of TNF-α
  36. The presence of bacteria species in semen and sperm quality
  37. CagA and VacA are Immunoblot Markers of Past Helicobacter pylori Infection in Atrophic Body Gastritis
  38. Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies☆
  39. Western Blotting of Total Lysate of Helicobacter pylori in Cases of Atrophic Body Gastritis
  40. Heterogeneity of cag genotypes and clinical outcome of Helicobacter pylori infection
  41. Prevalence of Helicobacter pylori Infection in Male Patients with Osteoporosis and Controls
  42. Increased phospholipase activity in strains isolated from patients with gastric carcinoma
  43. Helicobacter pyloriimmunoproteomes in case reports of rosacea and chronic urticaria
  44. Role of Noninvasive Tests (13C-Urea Breath Test and Stool Antigen Test) as Additional Tools in Diagnosis ofHelicobacter PyloriInfection in Patients with Atrophic Body Gastritis
  45. Inactivation of Helicobacter pylori cagA Gene Affects Motility
  46. Susceptibility of Helicobacter pylori to metronidazole
  47. Association of anti-GM1 antibodies but not of anti-cytomegalovirus, Campylobacter jejuni and Helicobacter pylori IgG, with a poor outcome in Guillain–Barré syndrome
  48. Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori
  49. Helicobacter pylori infection and infertility
  50. Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study
  51. The African Enigma: Low Prevalence of Gastric Atrophy, High Prevalence of Chronic Inflammation in West African Adults and Children
  52. Is there an antigenic mimicry between arteriosclerotic lesions and H. pylori antigens?
  53. Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development
  54. Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries
  55. Age, Helicobacter pylori, and/or CagA antibodies as a pre-endoscopic screening policy
  56. Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH
  57. Atrophic Gastritis and Intestinal Metaplasia in Helicobacter pylori Infection: The role of CagA status
  58. Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates
  59. Helicobacter pylori Infection, Chronic Gastritis, and Proton Pump Inhibitors
  60. In-vitro activity of lansoprazole against Helicobacter pylori
  61. Current Status and Future of Gastric Mucosal Protection and Repair Post-Conference Discussion
  62. Helicobacter pylori Factors Involved in the Development of Gastroduodenal Mucosal Damage and Ulceration
  63. Helicobacter pylori infection and primary Sjögren's syndrome: a possible association and new therapeutic approach
  64. The production of neuraminidase and fucosidase by Helicobacter pylori: Their possible relationship to pathogenicity
  65. Omeprazole versus ranitidine in the prevention of duodenal ulcer recurrence after eradication therapy
  66. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) ofHelicobacter pylori
  67. Comparisons between degree of histological gastritis and DNA fingerprints, cytotoxicity and adhesivity of Helicobacter pylori from different gastric sites
  68. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells
  69. Biotypes and DNA fingerprints of cytotoxigenicHelicobacter pylori from patients with gastritis and peptic ulceration in Italy
  70. Campylobacter spp isolated from dog faeces
  71. FAMILY OUTBREAK OF BLASTOCYSTIS HOMINIS ASSOCIATED GASTROENTERITIS
  72. CLINICAL CHARACTERISTICS OF CAMPYLOBACTER JEJUNI AND C COLI ENTERITIS
  73. Isolation of Different Species and/or Serogroups of Campylobacter from the Same Stool Sample
  74. Production of serum-opacity factor by Streptococcus pyogenes strains isolated from pharyngitis in children prevalence of ?rheumatogenic? M types among of-negative strains